Ken Griffin’s Citadel Investment Group Bullish on $AAPL $WFC $ETFC

Ken Griffin started trading stock options in 1986, between classes. By his sophomore year, he had enough to launch a convertible-bond arbitrage fund. The market crashed in 1987, just as he was buying, and Griffin struck it rich. By his senior year, Griffin had $1 million in investor money for the same strategy. Today, Griffin is a self-made billionaire and his Citadel Investment Group is one of the largest funds in the world.

Ken Griffin CITADEL INVESTMENT GROUP

When Ken Griffin founded Citadel Investment Group, officially, on November 1, 1990, it had $4.2 million in assets under management. According to a 13F filed with the SEC on February 14, Citadel Investment Group had a portfolio worth almost $44.32 billion, spread across 7,638 positions. In comparison, Citadel Investment Group had just under $41.24 billion in its portfolio, across 7,803 positions, at the end of the third quarter.

The largest of these positions is Apple (AAPL). Griffin had a position in the company worth $1.1 billion or almost 2.80 million shares, at the end of the fourth quarter. We don’t blame Griffin for being bullish about Apple – we are too, so is David Shaw’s D E Shaw. It is a great stock. Analysts like FBR Capital and Mizuho are saying, “buy,” or at least “market outperform,” and with good reason. Apple’s share price is expected to increase over 13% in the next year – it opened trading on February 17 at $503.18 on a mean one-year target estimate of $569.51 (range $270 to $700) – and it is priced low at 10.61 times its forward earnings.

Comparing Apple to its rival Hewlett Packard (HPQ) reveals one of the reasons why Apple is trading at a discount. Hewlett Packard is priced lower relative to its future earnings, with a forward P/E of just 6.60. Tech stocks, especially those related to personal computers, are trading at a discount. Microsoft (MSFT) and Dell (DELL) also have very low forward P/E ratios. The only thing that can justify such low P/E ratios for these stocks is a huge price war where profit margins shrink considerably. So far that’s not the case. These stocks gained around 25% over the past four months but we still think they are cheap.

Ken Griffin nearly doubled his fund’s position in Wells Fargo (WFC) during the fourth quarter, making it one of the largest positions in Citadel’s portfolio as of the end of December. It had $231 million in the company, or 8.38 million shares in the company at the end of the fourth quarter, compared to 4.28 million shares at the end of the third quarter.

As of the open of trading on February 17, Wells Fargo was trading at $30.56 a share on a mean one-year target estimate of $34.78 a share (range $25.45 to $45.00). The company also pays a 48 cents dividend (1.60% yield) and is priced low at 8.57 times its forward earnings. Warren Buffett’s Berkshire Hathaway is a big fan. It all sounds good, but compared to JP Morgan Chase (JPM), its closest competitor, JP Morgan is the winner. JPM has greater upside – it opened trading on February 17 at $38.60 a share on a mean one-year target estimate of $46.36 a share and it pays a $1.00 dividend (2.70% yield). JP Morgan is also priced lower at 7.15 times its forward earnings. Mega-cap financial stocks are another segment of the market where investors are extremely cautious. We believe a diversified portfolio of mega-cap banks will provide some protection and ample upside for contrarian investors.

Ken Griffin remained unchanged in his support of E*Trade Financial (ETFC). He maintained the same 27.4 million shares it had had at the end of the third quarter, however the value of that investment fell, moving to $249.83 at the end of September to $218.10 million at the end of December. E*Trade opened trading on February 17 at $9.29 a share, past its mean one-year target estimate of $9.25 (range $8 to $10). The stock does not pay a dividend either and with a forward P/E of 13.03 it is priced a little high. Looking at E*Trade competitor TD Ameritrade (AMTD), this sentiment is even more pronounced. TD Ameritrade opened trading on February 17 at $17.57 a share with a mean one-year target estimate of $18.74 a share (range $15 to $24). In addition to the upside, TD Ameritrade pays a 24 cents dividend (1.40% yield). It has a little higher forward P/E, but only marginally at 13.36. With all this, we would heartedly recommend TD Ameritrade over E*Trade to investors looking to invest in this market.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!